Abstract
Data on the influences of diabetes mellitus on the severity of ischemic damage to the myocardium are contradictory. We report here experiments using a model based on in vivo myocardial infarcts resulting from coronary occlusion to study the resistance of the myocardium in rats with alloxan-induced insulin-dependent diabetes mellitus to prolonged ischemia, along with studies of the infarct-limiting efficacy of ischemic preconditioning. The results showed that after diabetes mellitus for six weeks, the relative size of infarcts was significantly less than in controls (39.8 ± 8.8 and 62.3 ± 6.6% of the size of the anatomical risk zone respectively, p < 0.01). In addition, animals with diabetes mellitus developed ischemic ventricular tachyarrhythmia significantly less often than controls. A single episode of ischemic preconditioning in animals with diabetes mellitus had a less marked infarct-limiting effect than the same procedure in controls. Thus, these data support the existence of an endogenous cardioprotective phenotype (metabolic preconditioning) in experimental diabetes. On the other hand, the efficacy of ischemic preconditioning was sharply decreased in diabetes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
N. N. Petrishchev, E. V. Shlyakhto, T. D. Vlasov, and M. M. Galagudza, “Ischemic adaptation of the myocardium: pathophysiological mechanisms and possible potentials for practical application (literature review),” Ros. Fiziol. Zh. im. I. M. Sechenova, 87, No. 5, 688–705 (2001).
S. Bakth, J. Arena, W. Lee, R. Torres, B. Haider, B. C. Patel, M. M. Lyons, and T. J. Regan, “Arrhythmia susceptibility and myocardial composition in diabetes. Influence of physical conditioning,” J. Clin. Invest., 77, No. 2, 382–395 (1986).
D. Feuvray and G. D. Lopaschuk, “Controversies on the sensitivity of the diabetic heart to ischemic injury: the sensitivity of the diabetic heart to ischemic injury is decreased,” Cardiovasc. Res., 34, No. 1, 113–120 (1997).
R. Forrat, L. Sebbag, N. Wiernsperger, J. Guidollet, S. Renaud, and M. de Lorgeril, “Acute myocardial infarction in dogs with experimental diabetes,” Cardiovasc. Res., 27, No. 11, 1908–1912 (1993).
G. Hadour, R. Ferrera, L. Sebbag, R. Forrat, J. Delaye, and M. de Lorgeril, “Improved myocardial tolerance to ischaemia in the diabetic rabbit,” J. Mol. Cell. Cardiol., 30, No. 9, 1869–1875 (1998).
A. M. Murcia, C. H. Hennekens, G. A. Lamas, M. Jimenez-Navarro, J. L. Rouleau, G. C. Flaker, S. Goldman, H. Skali, E. Braunwald, and M. A. Pfeffer, “Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction,” Arch, Intern. Med., 164, No. 20, 2273–2279 (2004).
C. E. Murry, R. B. Jennings, and K. A. Reimer, “Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium,” Circulation, 74, No. 5, 1124–1136 (1986).
D. J. Paulson, “The diabetic heart is more sensitive to ischemic injury,” Cardiovasc. Res., 34, No. 1, 104–112 (1997).
T. Ravingerova, J. Neckar, and F. Kolar, “Ischemic tolerance of rat hearts in acute and chronic phases of experimental diabetes,” Mol. Cell. Biochem., 249, No. 1–2, 164–174 (2003).
T. Ravingerova, R. Stetka, D. Pancza, O. Ulicna, A. Ziegelhoffer, and J. Styk, “Susceptibility to ischemia-induced arrhythmias and the effect of preconditioning in the diabetic rat heart,” Physiol. Res., 49, No. 5, 607–616 (2000).
P. H. Stone, J. E. Muller, T. Hartwell, B. J. York, J. D. Rutherford, C. B. Parker, Z. G. Turi, H. W. Strauss, J. T. Willerson, and T. Robertson, “The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infraction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group,” Amer. J. Cell. Cardiol., 14, No. 1, 49–57 (1989).
A. Tosaki, D. T. Engelman, R. M. Engelman, and D. K. Das, “The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts,” Cardiovasc. Res., 31, No. 4, 526–536 (1996).
M. J. Walker, M. J. Curtis, D. J. Hearse, R. W. Campbell, M. J. Jance, D. M. Yellon, S. M. Cobbe, S. J. Coker, J. B. Harness, D. W. Harron, A. J. Higgins, D. G. Julian, M. L. Lab, A. S. Manning, B. J. Northover, J. R. Parratt, R. A. Riemersma, E. Riva, D. C. Russell, D. J. Sheridan, E. Winslow, and B. Woodward, “The Lambeth Conventions: guidelines for the study of arrhythmias in ischemia, infarction, and reperfusion,” Cardiovasc. Res., 22, No. 7, 447–455 (1988).
D. M. Yellon and J. M. Downey, “Preconditioning the myocardium: from cellular physiology to clinical cardiology,” Physiol. Rev., 83, No. 4, 1113–1151 (2003).
G. Zuanetti, R. Latini, A. P. Maggioni, L. Santoro, and M. G. Franzosi, “Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study,” J. Amer. Cell. Cardiol., 22, No. 7, 1788–1794 (1993).
Author information
Authors and Affiliations
Additional information
__________
Translated from Rossiiskii Fiziologicheskii Zhurnal imeni I. M. Sechenova, Vol. 92, No. 3, pp. 284–291, March, 2006.
Rights and permissions
About this article
Cite this article
Galagudza, M.M., Nekrasova, M.K., Syrenskii, A.V. et al. Resistance of the myocardium to ischemia and the efficacy of ischemic preconditioning in experimental diabetes mellitus. Neurosci Behav Physiol 37, 489–493 (2007). https://doi.org/10.1007/s11055-007-0040-5
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11055-007-0040-5